The unexpected formation of biologically active Cu(II) Schiff mono-base complexes with 2-thiophene-carboxaldehyde and dipropylenetriamine: crystal and molecular structure of CudptaSCl2

Two novel mononuclear Cu(II) coordination compounds of the type [Cu(dptaS)Cl(2)] and [Cu(dptaS)Br(2)] (dptaS=1,3-propanediamine, N(1)-[3-aminopropyl]-N(3)-[2-thienylmethylidene] or Schiff mono-base of dipropylenetriamine with 2-thiophene-carboxaldehyde) were prepared by the hydrolysis of the di-bases, [Cu(dptaSS)Cl(2)] and [Cu(dptaSS)Br(2)] (dptaSS=1,3-propanediamine, N(1)-[2-thienylmethylidene]-N(3)-[[2-thienylmethylidene]aminopropyl] or Schiff di-base of dipropylenetriamine with 2-thiophenecarboxaldehyde) to mono-bases with the release of one aldehyde molecule and freeing of the -NH(2) group of the coordinated dpta ligand. The X-ray determined structure of the compound [Cu(dptaS)Cl(2)] was confirmed by spectroscopic methods, magnetic and molar conductivity measurements. The Cu(II) atom is a five-coordinated CuN(3)Cl(2) chromophore with three nitrogen atoms coming up from the (dptaS) ligand and two chlorine atoms completing the square pyramidal geometry. Antiproliferative activity of both novel compounds was examined against a panel of different normal and cancer cell lines (MRC5, HeLa, MCF7, HT-29 and T47D) and showed that the Cu(II) Schiff mono-bases exhibit increased activity as compared to the starting materials. In vitro studies of plasmid DNA (pDNA) and double stranded DNA (dsDNA) interaction with the compounds under study support this difference. Some of the important factors contributing to the antiproliferative activity of the compounds under study, such as ionic character and dipole moment were also discussed in terms of the density functional theory calculated electronic structures of the ligands and their Cu(II) compounds.     

Copper(II) Schiff base coordination compounds of dien with heterocyclic aldehydes and 2-amino-5-methyl-thiazole: synthesis, characterization, antiproliferative and antibacterial studies. Crystal structure of CudienOOCl2

A new series of coordination compounds of the starting materials [Cu(dienX(2)Y(2))] and their adducts [Cu(dienXXY(2))(2a-5mt)] (where dien=diethylenetriamine, dienXX=Schiff bases of diethylenetriamine with 2-furaldehyde or 2-thiophene-carboxaldehyde, X=O, S, Y=Cl, Br, NO(3) and 2a-5mt=2-amino-5-methylthiazole) were synthesized by stepwise reactions and their structures were established by C, H, N, Cu analysis, spectroscopic, magnetic and molar conductivity measurements. The isolated compounds are monomers, paramagnetic and electrolytic compounds of the type 1:1. In all cases, the pentadentate Schiff base (dienXX) is bonded in a tridentate fashion through the 3 N atoms. In the CudienXXY(2) compounds the coordination sphere is completed by two Cl or Br or NO(3) groups in a square pyramidal arrangement. The proposed structure for this type of compound was further supported by X-ray diffraction analysis of the compound [Cu(dienOO)Cl(2)]. Its basal plane consists of three Cu-N contacts [2.017(2), 2.025(2) and 2.012(2) A] from dienOO, and the Cl(1) atom, while the Cl(2) atom possesses the apical position, the relevant distances being 2.2732(7) A for Cu-Cl(1) and 2.6051(7) A Cu-Cl(2). In the CudienX(2)Y(2).2a-5mt adducts the coordination sphere of copper is further completed by the nitrogen ring atom of the 2a-5mt, forming an octahedral configuration. The study of the biological activity of the compounds synthesized against a panel of different normal and cancer cell lines (MRC5, HeLa, MCF7, HT-29, OAW42, T47D) and bacteria (E. coli, B. cereus, B. subtilis) showed that the adducts of the type [Cu(dienXXY(2))(2a-5mt)] exhibit increased activity both in cancer cells and in bacteria, compared to the starting material of type [Cu(dienXXY(2))].     

Copper(II) Complexes Derived from Schiff Bases Containing 4-Methylbenzylamine as a Core Unit: Cytotoxicity,pBR322-DNA Studies,Biological Assays,and Quantum Chemical Parameters

Bivalent copper complexes, [Cu(SB¹)₂] 1 (SB¹=(2-(4-methylbenzylimino)methyl)-5-methylphenol, [Cu(SB²)₂] 2 (SB²=(2-(4-methylbenzylimino)methyl)-4-bromolphenol), and [Cu(SB³)₂] 3 (SB³=(2-(4-methylbenzylimino)methyl)-4,6-dibromophenol) were synthesized using the Schiff bases prepared from 4-methylbenzylamine (p-tolylmethanamine). These were characterized using a variety of spectro-analytical methods. For all copper complexes, a square planar geometry was determined through spectral analyses. Utilizing molecular orbital energies, the stability of the copper complexes was calculated from quantum chemical characteristics. The kinetic and thermal degradation parameters were calculated from the thermograms. Studies on DNA binding interactions, such as UV absorption and emission, have shown that the manner of DNA binding is intercalative, and the binding constant (K_b) order is 3 > 2 > 1 . Under oxidative and photolytic techniques, the copper complexes outperform the parent Schiff bases in their ability to cleave double-stranded pBR322 DNA. When tested for cytotoxicity on the KB3 and MCF7 cell lines, complexes displayed greater activity than their parent ligands. Studies on the complexes′ in-vitro antibacterial and antioxidant activity showed that they are significantly more powerful than the parent ligands.     

Copper(II) complexes of tetradentate thioether-oxime ligands

Two dinuclear copper(II) thioether-oxime complexes ([Cu(DtdoH)]₂(ClO₄)₂ and [Cu(DtudH)]₂(ClO₄)₂ · 2CH₃OH) have been synthesized. [Cu(DtdoH)]₂(ClO₄)₂ reacted with excess BF₃ · OEt₂ to yield [Cu(Thyclops)]ClO₄, a -macrocyclized di-oxime. [Cu(DtdoH)]₂(ClO₄)₂ and [Cu(DtudH)]₂(ClO₄)₂ · 2CH₃OH are the first representatives of copper(II) thioether oximes which exhibit the classical out-of-plane oximate oxygen-metal dimer structure. [Cu(DtdoH)]₂(ClO₄)₂ and [Cu(Thyclops)]ClO₄ have been structurally characterized by single-crystal X-ray diffraction. The geometry about each copper(II) in [Cu(DtdoH)]₂(ClO₄)₂ is a distorted square pyramid (τ = 0.14). The average copper-nitrogen(oxime) bond length is 1.984 Å longer (∼0.03 Å) than the average copper-nitrogen(oxime) bonds in copper(II) bis-glyoximates. The geometry of [Cu(Thyclops)]ClO₄ reveals an almost perfect square pyramid (τ = 0.03) of N₂S₂O donors. Solution, cryogenic glass, and powder ESR spectra show a typical axial pattern, except for the powder spectrum of [Cu(DtudH)]₂(ClO₄)₂ · 2CH₃OH which displays a small rhombic distortion. Variable-temperature magnetic susceptibility measurements indicate very weak ferromagnetic interactions in [Cu(DtdoH)]₂(ClO₄)₂, where J = +0.52 cm⁻¹ and very weak antiferromagnetic interactions in [Cu(DtudH)]₂(ClO₄)₂ · 2CH₃OH, where J = −0.59 cm⁻¹. Electrochemical measurements reveal that the mixed thioether-oxime coordination environment tends to stabilize Cu(II), as all electrochemical reductions were quasi-reversible or irreversible. [Cu(Thyclops)]ClO₄ is more oxidizing than [Cu(DtdoH)]₂(ClO₄)₂ by 0.14 V.     

Copper(I) complexes with Schiff base and 1,2-bis(diphenylphosphino)ethane as ligands: Synthesis, structure and catalytic properties for the amination of aryl halide

Some copper(I) complexes of the type [Cu(L)(dppe)]X (1-4) [where L = (3-trifluoromethylphenyl)pyridine-2-ylmethylene-amine; dppe = 1,2-bis(diphenylphosphino)ethane; X = Cl⁻, CN⁻, ClO₄⁻ and BF₄⁻] have been synthesized by the condensation of 3-aminobenzotrifluoride with 2-pyridinecarboxaldehyde followed by the reaction with CuCl, CuCN, [Cu(MeCN)₄]ClO₄ and [Cu(MeCN)₄]BF₄ in presence of dppe. The complexes 1-4 were then characterized on the basis of elemental analysis, IR, UV-Vis and ¹H NMR spectral studies. The representative complex of the series 4 has been characterized by single crystal X-ray diffraction which reveal that in complex the central copper(I) ion assumes the irregular pseudo-tetrahedral geometry. The catalytic activity of the complexes was tested and it was found that all the complexes worked as effective catalyst in the amination of aryl halide.     

Copper(II) PMDTA and copper(II) TMEDA complexes: precursors for the synthesis of dinuclear dicationic copper(II) complexes

Copper(II) cations coordinated with PMDTA (pentamethyldiethylenetriamine) and TMEDA (tetramethylethylenediamine) possess a high synthetic potential. The synthesis of these cations was carried out by metathesis reactions with silver salts. The cationic copper(II) complexes, [Cu(PMDTA)(Me₂CO)Cl]⁺, [Cu(PMDTA)(H₂O)Cl]⁺, [Cu(PMDTA)(DMF)]⁺, [Cu(PMDTA)Cl]⁺, [Cu(PMDTA)OAc]⁺, [Cu(PMDTA)(MeCN)₂]²⁺, [Cu₂(TMEDA)₂Cl₃]⁺ and [Cu(TMEDA)(MeCN)₃]²⁺ were synthesised as PF₆ salts, crystallised and characterised by single-crystal X-ray diffraction.     

Zinc(II) and copper(II) 1D coordination polymeric complexes of a reduced Schiff base ligand

The reaction of Zn(ClO₄)₂ · 6H₂O and Cu(ClO₄)₂ · 6H₂O with H₃Sas (H₃Sas = N-(2-hydroxybenzyl)-L-aspartic acid in water afforded the complexes [Zn₆(Sas)₄(H₂O)₈]·5H₂O (1) and [Cu(HSas)(H₂O)] (2), respectively, which were characterized by infrared spectroscopy, elemental analysis, thermogravimetry and single-crystal X-ray crystallography. In 1, the pentanuclear clusters formed by four H₃Sas ligands and five Zn(II) metal ions are bridged by the “[Zn(H₂O)₄]²⁺” cations to form 1D polymeric chains. While in 2, the mononuclear [Cu(HSas)(H₂O)] repeating units form a 1D zigzag chain and further extended by strong intermolecular hydrogen bonds to form a 2D sheet. The different coordination geometries of Cu(II) and Zn(II) show significant influence on the polymeric structures.     

Hydrogen-bonded copper(II) and nickel(II) complexes and coordination polymeric structures containing reduced Schiff base ligands

Complexes [Cu(HSas)(H₂O)] · 2H₂O (H₃Sas = N-(2-hydroxybenzyl)-l-aspartic acid) (1), [Cu(HMeSglu)(H₂O)] · 2H₂O (H₃MeSglu = (N-(2-hydroxy-5-methylbenzyl)-l-glutamic acid) (2), [Cu₂(Smet)₂] (H₂Smet = (N-(2-hydroxybenzyl)-l-methionine) (3), [Ni(HSas)(H₂O)] (4), [Ni₂(Smet)₂(H₂O)₂] (5), and [Ni(HSapg)₂] (H₂Sapg = (N-(2-hydroxybenzyl)-l-aspargine) (6) have been synthesized and characterized by chemical and spectroscopic methods. Structural determination by single crystal X-ray diffraction studies revealed 1D coordination polymeric structures in 2 and 4, and hydrogen-bonded network structure in 5 and 6. In contrast to previously reported coordination compounds with similar ligands, the phenol remains protonated and bonded to the metal ions in 2 and 4, and also probably in 1. However, the phenolic group is non-bonded in 6.     

Copper(II)-N2S2 complexes of the imines of 1-phenyl-3-formyl-2(1H)-pyridinethione

Several copper(II) complexes of the imines formed by condensation of 1-phenyl-3-formyl-2(1H)-pyridinethione and a primary amine (pyt-R) or a diamine (pyt₂-R′) have been synthesized and characterized. The complexes have a CuN₂S₂ core and the sulfur donors exhibit thiolate character. The complexes of type [Cu(pyt₂-R′)] [ClO₄]₂ display optical and ESR spectral behavior that indicates a progressive distortion of the metal coordination geometry from square- planar toward flattened tetrahedral as the carbon chain length of the R′ bridge is varied from two to four atoms. The spectral properties of the complexes of type [Cu(pyt-R)₂] [ClO₄]₂ are more similar to one another and indicate significant distortion of Cu(II) from the planar arrangement.     

Characterization and DNA-interaction studies of 1,1-dicyano-2,2-ethylene dithiolate Ni(II) mixed-ligand complexes with 2-amino-5-methyl thiazole, 2-amino-2-thiazoline and imidazole. Crystal structure of [Ni(i-MNT)(2a-5mt)2]

A series of mixed-ligand neutral nickel(II) complexes of the general formula [Ni(i-MNT)(2a-5mt)₂] (1), [Ni(i-MNT)(2a-2tzn)₂] (2) and [Ni(i-MNT)(Im)₂] (3), [where i-MNT^2? = the dianion of 1,1-dicyano-2,2-ethylenedithiolate, 2a-5mt = 2-amino-5-methyl thiazole, 2a-2tzn = 2-amino-2-thiazoline and Im = imidazole] were prepared and characterized with elemental analyses, spectroscopic (IR, UV–vis) methods, magnetic susceptibility, molar conductivity and cyclic voltammetry measurements. The magnetic data, the electronic spectra and the electrical conductivity measurements indicated mononuclear neutral complexes with square-planar geometry. The X-ray analysis of [Ni(i-MNT)(2a-5mt)₂] shows the nickel atom being fourfold coordinated with the two sulfur atoms of the dithiolate (i-MNT) ligand and the endocyclic nitrogen atoms from the two 2a-5mt ring giving rise to a slightly distorted square-planar arrangement. The cyclic voltammograms of the complexes have been recorded and the corresponding redox potentials have been estimated. The DNA-binding studies of the complexes has been evaluated by examining their ability to bind to calf-thymus DNA (CT DNA) with UV spectroscopy and cyclic voltammetry. Both studies have shown that the complexes can bind to CT-DNA by the intercalative and the electrostatic binding mode. Competitive binding studies with ethidium bromide (EB) with fluorescence spectroscopy have also shown that the complexes exhibit the ability to displace the DNA-bound EB indicating that they can bind to DNA in strong competition with EB.     

Ternary copper(II) complexes with hippurate derivatives and 1,10-phenanthroline: Synthesis and biological activity

Several new Cu-hippurate derivative-phenanthroline ternary complexes have been prepared. The X-ray structure of one of them, [Cu(hip)(phen)₂]⁺·(hip⁻) (2) (where hip is hippurate and phen is 1,10-phenanthroline) has been solved. The structure of this new compound shows important differences (3D-pattern) to other similar related complexes (2D-pattern). A study of the biological activity of [Cu(hip)(phen)₂]⁺·(hip⁻)·2H₂O (2), [Cu(BGG)(phen)₂]⁺·(BGG⁻)·6H₂O (3), [Cu(B^IGG)₂(phen)](H₂O) (4) and [Cu(I-hip)(bpy)₂]⁺·(I-hip⁻)·3.5H₂O (5) (where I-hip is ortho-iodohippurate, BGG corresponds to benzoylglycilglycine, and B^IGG is ortho-iodobenzoylglycilglycine) is included and compared with the anti-proliferative activity of [Cu(I-hip)(phen)₂]⁺·(I-hip⁻)·7H₂O (1) previously described, resulting in a greater cytotoxic activity of the compounds with 1,10-phenanthroline instead of those with 2,2′-bipyridyl, in the same way that removing iodine substitution or lengthening the peptidic chain diminishes the activity of compounds compared with 1. The presence of an ortho-iodine group and the direct bond between Ar-CO and glycine moieties yield to the best results.     

Copper(I)-organophosphine complexes of bis(3,5-dimethylpyrazol-1-yl)dithioacetate ligand

Copper(I) complexes have been synthesized from the reaction of CuCl, monodentate tertiary phosphines PR₃ (PR₃ = P(C₆H₅)₃; P(C₆H₅)₂(4-C₆H₄COOH); P(C₆H₅)₂(2-C₆H₄COOH); PTA, 1,3,5-triaza-7-phosphaadamantane; P(CH₂OH)₃, tris(hydroxymethyl)phosphine) and lithium bis(3,5-dimethylpyrazolyl)dithioacetate, Li[LCS₂]. Mono-nuclear complexes of the type [LCS₂]Cu[PR₃] have been obtained and characterized by elemental analyses, FT-IR, ESI-MS and multinuclear (¹H, ¹³C and ³¹P) NMR spectral data; in these complexes the ligand behaves as a κ³-N,N,S scorpionate system. One exception to this stoichiometry was observed in the complex [LCS₂]Cu[P(CH₂OH)₃]₂, where two phosphine co-ligands are coordinated to the copper(I) centre. The solid-state X-ray crystal structure of [LCS₂]Cu[P(C₆H₅)₃] has been determined. The [LCS₂]Cu[P(C₆H₅)₃] complex has a pseudo tetrahedral copper site where the bis(3,5-dimethylpyrazolyl)dithioacetate ligand acts as a κ³-N,N,S donor.     

Copper(II) compounds of the planar-tridentate ligand 2,6-bis(pyrazol-3-yl)pyridine

The tridentate ligand 2,6-bis(pyrazol-3-yl)pyridine (dPzPy) renders coordination compounds with halide, nitrate and tetrafluoroborate salts of copper. The complexes, which have the form [Cu(dPzPy)X₂] with X=Br and Cl, [Cu(dPzPy)(NO₃)₂](H₂O), and [Cu(dPzPy)₂](BF₄)(SiF₆)_0.5(MeOH)₃ have been characterized by elemental analysis and by IR, EPR and ligand field spectroscopy. The single-crystal X-ray structure of [Cu(C₁₁H₉N₅)Br₂] shows the copper(II) ion to be coordinated by three N atoms of 2,6-bis(pyrazol-3-yl)pyridine and two bromides in a geometry exactly in between a trigonal-bipyramid and a square-pyramid. Each molecule lies on a crystallographic C₂-symmetry axis. They are coupled to one another by a two-dimensional network through NH to Br hydrogen bonds. The crystal structure of [Cu(C₁₁H₉N₅)Cl₂] is analogous to the bromide. The single-crystal X-ray structure of [Cu(dPzPy)₂](BF₄)(SiF₆)_0.5(MeOH)₃ shows the copper ion to be in a Jahn-Teller distorted octahedral N₆ environment of two mer-oriented tridentate ligands.     

Anti-oxidant,in vitro,in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II)

Some new complexes of mefenamic acid with potentially interesting biological activity are described. The complexes of mefenamic acid [Mn(mef)₂(H₂O)₂], 1, [Co(mef)₂(H₂O)₂], 2, [Ni(mef)₂(H₂O)₂], 3, [Cu(mef)₂(H₂O)]₂, 4 and [Zn(mef)₂], 5, were prepared by the reaction of mefenamic acid, a potent anti-inflammatory drug with metal salts. Optical and infrared spectral data of these new complexes are reported. Monomeric six-coordinated species were isolated in the solid state for Mn(II), Ni(II) and Co(II), dimeric five-coordinated for Cu(II) and monomeric four-coordinated for Zn(II). In DMF or CHCl₃ solution the coordination number is retained and the coordinated molecules of water are replaced by solvent molecules. The anti-oxidant properties of the complexes were evaluated using the 1,1-diphenyl-2-picrylhydrazyl, DPPH, free radical scavenging assay. The scavenging activities of the complexes were measured and compared with those of the free drug and vitamin C. We have explored their ability to inhibit soybean lipoxygenase, β-glucuronidase and trypsin- induced proteolysis. The complex [Mn(mef)₂(H₂O)₂] exhibits the highest antioxidant activity and the highest inhibitory effect against the soybean lipogygenase (LOX), properties that are not demonstrated by mefenamic acid. Their inhibitory effects on rat paw edema induced by Carrageenan was studied and compared with those of mefenamic acid. The complex [Zn(mef)₂] exhibited a strong inhibitory effect at 0.1 mmol/Kg B.W. (81.5 ± 1.3% inhibition), superior to the inhibition induced by mefenamic acid at the same dose (61.5 ± 2.3% inhibition). Mefenamic acid and its metal complexes have been evaluated for antiproliferative activity in vitro against the cells of three human cancer cell lines: MCF-7 (human breast cancer cell line), T24 (bladder cancer cell line), A-549 (non-small cell lung carcinoma) and a mouse fibroblast L-929 cell line. The copper(II) complex displays against T24, MCF-7 and L-929 cancer cell lines, IC₅₀ values in a μM range similar to that of the antitumor drug cis-platin and they are considered for further stages of screening in vitro and/or in vivo as agents with potential antitumor activity.     

Ordering selected Zn(II), Cu(II), Pd(II) and Co(III) complex compounds: their separately and combinedly antibacterial therapy and DNA-binding studies

Abstract

In this study, four Co(III)-, Cu(II)-, Zn(II)- and Pd(II)-based potent antibacterial complexes of formula K₃[Co(ox)₃]·3H₂O (I), [Cu(phen)₂Cl]Cl·6.5H₂O (II), [Zn(phen)₃]Cl₂ (III) and [Pd(phen)₂](NO₃)₂ (IV) (where ox is oxalato and phen is 1,10-phenanthroline) were synthesized. They were characterized by elemental analysis, molar conductivity measurements, UV–vis, Fourier transform infrared (FT-IR) and proton nuclear magnetic resonance (¹H-NMR) techniques. These metal complexes were ordered in three combination series of I+II, I+II+III and I+II+III+IV. Antibacterial screening for each metal complex and their combinations against Gram-positive and Gram-negative bacteria revealed that all compounds were more potent antibacterial agents against the Gram-negative than those of the Gram-positive bacteria. The four metal complexes showed antibacterial activity in the order I > II > III > IV, and the activity of their combinations followed the order of I+II+III+IV > I+II+III > I+II. The DNA-binding properties of complex (I) and its three combinations were studied using electronic absorption and fluorescence (ethidium bromide displacement assay) spectroscopy. The results obtained indicated that all series interact effectively with calf thymus DNA (CT-DNA). The binding constant (K_b), the number of binding sites (n) and the Stern–Volmer constant (K_sv) were obtained based on the results of fluorescence measurements. The calculated thermodynamic parameters supported that hydrogen bonding and van der Waals forces play a major role in the association of each series of metal complexes with CT-DNA and follow the above-binding affinity order for the series.

Communicated by Ramaswamy H. Sarma     

Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity

Some new complexes of meclofenamic acid (N-(2,6-dichloro-m-tolyl)anthranilic acid), Hmeclo (1), with potentially interesting biological activities are described. Complexes [Mn(meclo)₂] (2), [Cu(meclo)₂(H₂O)₂] (3), [Zn(meclo)₂(H₂O)₂] (4) and [Cd(meclo)₂(H₂O)₂] (5) were prepared and structurally characterized by means of vibrational, electronic and ¹H and ¹³C NMR spectroscopies. The crystal structure of complexes [Cu₄(meclo)₆(OH)₂(DMSO)₂]2DMSO (3a) and [Cd(meclo)₂(DMSO)₃] (5a) have been determined by X-ray crystallography. Complex (3a) is a centrosymmetric tetramer built up around the planar cyclic Cu₂(OH)₂ unit. Complex 5a is mononuclear seven-coordinated complex with the meclofenamato ligand behaving as a bidentate deprotonated chelating ligand. Intra and intermolecular hydrogen bonds stabilize these two structures, while the crystal packing is determined by π-π and C−H−-π interactions. Meclofenamic acid and its metal complexes have been evaluated for antiproliferative activity in vitro against the cells of three human cancer cell lines, MCF-7 (breast cancer cell line), T24 (bladder cancer cell line), and A-549 (non-small cell lung carcinoma), and a mouse fibroblast L-929 cell line. Complex 5 exhibits the highest selectivity against MCF-7 and 4 shows the highest selectivity against T-24. Complexes 2-5 were found to be more potent cytotoxic agents against T-24 and complex 5 against MCF-7 cancer cell lines than the prevalent benchmark metallodrug, cis-platin. The superoxide dismutase activity was measured by the Fridovich test which showed that complex [Cu(meclo)₂(H₂O)₂] is a good superoxide scavenger.     

Molecular Orbital Study of the Magnetic Properties of Pyrazine- and Pyrimidine-Bridged Copper(II) Complexes

Magnetic interactions in the three copper(II)-complex polymers, [Cu(PZ)(NO₃)₂]_n, [Cu(PM)(NO₃)₂(H₂O)₂]_n, and [Cu(PM)₂(NO₃)₂]_n are discussed on the basis of extended Hückel calculations inthe formulas PZ and PM stand for pyrazine and pyrimidine, respectively. Interactions between the Cu-3d orbitals and the lone-pair orbitals of pyrazine and pyrimidine are analyzed from the viewpoint of `through-space' and `through-bond' interactions using binuclear complexes to model the three copper(II) polymers. Three conclusions can be drawn from the orbital interaction analysis: (1) in the first polymer, a superexchange pathway is formed with the bond of Cu–-N and the through-bond interaction between the lone pairs of the nitrogen atoms of pyrazine will lead to an antiferromagnet state; (2) in the second polymer a superexchange pathway is formed with the bond of Cu–-N and the through-space interaction between the lone pairs of the nitrogen atoms of pyrimidine, and as a result an antiferromagnetic state will be preferred; and (3) in the third polymer., there is no effective pathway in respect of overlap interaction and the HOMO and the LUMO are actually degenerate, and thus a ferromagnetic state will arise. The band structures are analyzed to characterize the magnetic properties of the antiferromagnetic polymers, [Cu(PZ)(NO₃)₂]_n and [Cu(PM)(NO₃)₂(H₂O)₂], and the ferromagnetic polymer, [Cu(PM)₂(NO₃)₂]_n.     

Synthesis,characterization, cytotoxicity,and DNA binding of some new platinum(II) and platinum(IV) complexes with benzimidazole ligands

In this study, two Pt(II) and three Pt(IV) complexes with the structures of [PtL₂Cl₂] (1), [PtL₂I₂] (2), [PtL₂Cl₂(OH)₂] (3), [PtL₂Cl₂(OCOCH₃)₂] (4), and [PtL₂Cl₄] (5) (L = benzimidazole as carrier ligand) were synthesized and evaluated for their in vitro antiproliferative activities against the human MCF-7, HeLa, and HEp-2 cancer cell lines. The influence of compounds 1–5 on the tertiary structure of DNA was determined by their ability to modify the electrophoretic mobility of the form I and II bands of pBR322 plasmid DNA. The inhibition of BamH1 restriction enzyme activity of compounds 1–5 was also determined. In general, it was found that compounds 1–5 were less active than cisplatin and carboplatin against MCF-7 and HeLa cell lines (except for 1, which was found to be more active than carboplatin against the MCF-7 cell line). Compounds 1 and 3 were found to be significantly more active than cisplatin and carboplatin against the HEp-2 cell line.     

Copper(II), cobalt(II) and nickel(II) complexes of lapachol: synthesis,DNA interaction,and cytotoxicity

Three novel copper(II), cobalt(II), and nickel(II) complexes of lapachol (Lap) containing 110-phenanthroline (phen) ligand, [M(Lap)₂(phen)] (M=Cu(II), 1, Co(II), 2, and Ni(II), 3), have been synthesized and characterized using, elemental analysis and spectroscopic studies. Their interactions with calf thymus DNA (CT DNA) were investigated using viscosity, thermal denaturation, circular dichorism, fluorescence quenching, and electronic absorption spectroscopy. The DNA cleavage abilities of 1–3 have been studied, where cleavage activity of copper complex 1 is more than the complexes 2 and 3. The in vitro cytotoxic potential of the complexes 1–3 against human cervical carcinoma (HeLa), human liver hepatocellular carcinoma (HepG-2), and human colorectal adenocarcinoma (HT-29) cells indicated their promising antitumor activity with quite low IC₅₀ values in the range of .15–2.41 μM, which are lower than those of cisplatin.     

Syntheses, structures and properties of copper(II) complexes containing N-(2-hydroxybenzyl)-amino amide ligands

Four copper(II) complexes containing the reduced Schiff base ligands, namely, N-(2-hydroxybenzyl)-glycinamide (Hsglym) and N-(2-hydroxybenzyl)-l-alaninamide (Hsalam) have been synthesized and characterized. The crystal structures of [Cu₂(sglym)₂Cl₂] (1), [Cu₂(salam)₂(NO₃)₂] · H₂O (3), [Cu₂(salam)₂(NO₃)(H₂O)](NO₃) · 1.5H₂O (4), [Cu₂(salam)₂](ClO₄)₂ · 2H₂O (5) show that the Cu(II) atoms are bridged by two phenolato oxygen atoms in the dimers. The sglym ligand bonded to Cu(II) in facial manner while salam ligand prefers to bind to Cu(II) in meridonal geometry. Variable temperature magnetic studies of 3 showed it is antiferromagnetic. These Cu(II) complexes and [Cu₂(sglym)₂(NO₃)₂] (2), exhibit very small catecholase activity as compared to the corresponding complexes containing acid functional groups.